Achieving Response in Older Patients with MDS

You need to be logged in to continue. Please Log In or Register using the box at the top right of this page.

Release Date: November 08, 2017
Expiration Date: November 08, 2018

Expected time to complete this activity as designed: 30 minutes

There are no fees for participating in or receiving credit for this online activity.

Program Overview

The treatment and management of older patients with MDS is extremely challenging due to a number of reasons, including advanced disease, intolerability to therapy, significant comorbidities, and potential for more drug-drug interactions with concomitant therapy. These issues, which may not affect every older patient with MDS, can result in age bias when designing treatment goals and selecting therapy, thus ignoring individual patient factors. In this activity, participants will learn how to tailor the aggressiveness of therapy to the individual older patient with MDS, taking into account factors beyond age itself, such as performance status and fitness level. In addition, participants will learn about different strategies for achieving response in older patients with MDS who may or may not tolerate therapy, including dose-modifications and supportive care.

Target Audience

This activity is designed for physicians, pharmacists, physician assistants, and other health care professionals who have an interest in enhancing their clinical skills in myelodysplastic syndromes.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Differentiate older patients with MDS based on biological fitness to select appropriate therapy
  • Describe the role of allogeneic stem cell transplant in older patients with MDS
  • Recognize strategies for achieving response in older patients challenged with tolerating therapy


Achieving Response in Older Patients with MDS – Stuart Goldberg, MD

Instructions for Participation and Credit

This activity is eligible for credit through November 8, 2018. After this date, this activity will expire and no further credit will be awarded.

  1. Read the target audience, learning objectives, and faculty disclosures.
  2. You may be asked to complete a short pre-test before accessing the educational content. This must be completed in order to move forward in the activity.
  3. Complete the educational content as designed.
  4. Complete the post-test. To receive a certificate, you must receive a passing score of 70%.
  5. Complete the activity evaluation survey to provide feedback and information useful for future programming.
  6. Certificates for CME may be printed immediately after successfully completing the post-test and activity evaluation. Pharmacist credit will be uploaded to CPE Monitor 4 weeks following receipt of a completed, qualified form.

Faculty Biography

Stuart Goldberg, MD
Division of Leukemia
John Theurer Cancer Center
Hackensack University Medical Center
Associate Clinical Professor of Medicine
Rutgers New Jersey Medical School
Hackensack, New Jersey

Dr. Stuart Goldberg received his medical degree from Pennsylvania State University. He completed his internal medical residency and hematology-oncology fellowships at George Washington University Medical Center, and served as a bone marrow transplant fellow at the Mayo Clinic. Dr. Goldberg is a member of the Division of Leukemia at the John Theurer Cancer Center at Hackensack University Medical Center and Associate Clinical Professor of Medicine at Rutgers: New Jersey Medical School. He also is the Chief Scientific Officer at COTA, Inc., a medical data and analytics company.

Dr. Goldberg currently serves on the Development Board of the MDS Foundation and established an MDS Center of Excellence program at his hospital. His research efforts earned him the 2015 David King Clinical Scientist Award from the Association of Community Cancer Centers (ACCC). His clinical and research interests are in the myelodysplastic syndromes, with particular emphasis on strategies to reduce transfusion related iron overload.


Accreditation Statement: MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is acceptable for 0.5 contact hours of Continuing Education Credit. Universal Activity Number: 827-0000-17-179-H01-P. Knowledge-based CPE activity.

In order for CPE Monitor to authenticate credit, pharmacists/technicians must provide their e-Profile ID number from NABP and date of birth (in MMDD format) when claiming credit for a CPE program.


As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE) and California State Board of Registered Nursing, MediCom Worldwide, Inc. requires everyone who is in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest. Accordingly, the following disclosures were made.

Faculty Disclosure

Dr. Stuart Goldberg has received honoraria related to speakers’ bureau activities from Celgene Corporation and Novartis AG. He has been employed by COTA (Cancer Outcomes Tracking Analysis).

Planning Committee Disclosures

The individual listed below from MediCom Worldwide, Inc. reported the following for this activity: Joan Meyer, RN, MHA, Executive Director, has no relevant financial relationships.

Peer Reviewer Disclosure

In accordance with MediCom Worldwide, Inc. policy, all content is reviewed by external independent peer reviewers for balance, objectivity and commercial bias. The peer reviewers have no relevant financial relationships to disclose.

If you have any questions or concerns regarding this activity, please contact MediCom Worldwide, Inc. at 1-800-408-4242 or email us at

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Celgene Corporation.

©2017 MediCom Worldwide, Inc., 101 Washington St., Morrisville, PA 19067, 800-408-4242.
No portion of this material may be copied or duplicated without the expressed permission of MediCom Worldwide, Inc.

You need to be logged in to continue. Please Log In or Register using the box at the top right of this page.